Post-acute COVID-19 in three doses vaccinated autoimmune rheumatic diseases patients: frequency and pattern of this condition.
Clovis Artur SilvaLeonard de Vinci Kanda KupaAna Cristina Medeiros-RibeiroSandra Gofinet PasotoCarla Gonçalves Schahin SaadEmily Figueiredo Neves YukiJoaquim Ivo Vasques Dantas LandimVictor Hugo Ferreira E LédaLuisa Sacchi de Camargo CorreiaArtur Fonseca SartoriCarolina Campagnoli Machado Freire MartinsCarolina Torres RibeiroFilipe WaridelVictor Adriano de Oliveira MartinsSamuel Katsuyuki ShinjoDanieli Castro Oliveira AndradePercival Degrava Sampaio BarrosEduardo Ferreira Borba NetoNadia Emi AikawaEloisa S BonfaPublished in: Advances in rheumatology (London, England) (2023)
We provide novel data demonstrating that immune/inflammatory ARD disturbances after third dose vaccination do not seem to be a major determinant of post-acute COVID-19 since its pattern is very similar to that of the general population. Clinical Trials platform (NCT04754698).
Keyphrases
- coronavirus disease
- sars cov
- liver failure
- end stage renal disease
- clinical trial
- drug induced
- respiratory failure
- ejection fraction
- chronic kidney disease
- newly diagnosed
- aortic dissection
- oxidative stress
- peritoneal dialysis
- randomized controlled trial
- extracorporeal membrane oxygenation
- electronic health record
- deep learning
- machine learning
- single cell
- patient reported
- artificial intelligence